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The Lancefield group A streptococci (Strepto-
coccus pyogenes), major causative agents of
human disease (1), can produce both mild (e.g.,
pharyngitis) and severe (e.g., life-threatening
toxic shock-like syndrome, necrotizing fasciitis)
infections. During the last few years, erythromy-
cin-resistant  S. pyogenes (ErR) has been
reported in different parts of the world (2-4). Two
distinct mechanisms of erythromycin resistance
are described among group A streptococci. One
consists of target-site modification by erm
methylase (5,6) strains that express the MLSb
phenotype of resistance; the other (recently
described) consists of an active drug efflux that
pumps 14- and 15-membered macrolides out of
the cell (7). This novel mechanism of macrolide
resistance is encoded by the gene mefA (8), and
strains show the M phenotype. In the last few
years, increased resistance to erythromycin in
S. pyogenes has been detected in Spain (9-11).
Therefore, we performed an epidemiologic
investigation to determine the biotypes, sero-
types (T-agglutination patterns), emm types,
and pulsed-field gel electrophoresis (PFGE)
patterns of chromosomal DNA and their
relationship to macrolide resistance.
The Study
Sources of Bacterial Isolates
From 1988 to 1997, 2,561 nonduplicated
isolated strains of S. pyogenes were collected
from throat swabs and extratonsilar samples at
the Nuestra Señora de Aránzazu Hospital and at
primary-care centers in two districts of Gipuzkoa
(approximately 300,000 residents). In 1996, two
other samples were collected and included in this
study; 33 ErR strains from Vitoria (Hospital
Txagorritxu) and 95 from Madrid (Centro de
Especialidades Argüelles). Gipuzkoa Province
(San Sebastian is its capital) is located in the
northeastern area of the Basque country of
Spain, bordered by the Cantabric Sea and France
to the north; Madrid is located in the center of
Spain (415 km from San Sebastian); and Vitoria
(in Alava Province) is located in the north of
Spain (110 km from San Sebastian).
Identification, Susceptibility, Typing, and
Clone Definition
Group A streptococci were identified by
colony morphology, beta-hemolysis on blood
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agar, and commercial latex-agglutination tech-
niques (Streptex, Wellcome, Dartford, UK, or
Phadebact, Boule Diagnostics AB, Huddinge,
Sweden). The confirmation of S. pyogenes and
biotyping were done with a commercially
available identification system: rapid ID 32
STREP (BioMerieux, La Balme-les-Grottes,
France). Biotyping was performed according to
Bouvet et al. (12).
All S. pyogenes were tested for susceptibility
to erythromycin and other antibiotics by broth
microdilution. ErR strains were restudied by
agar dilution and by agar diffusion (erythromy-
cin induction of resistance) to determine
macrolide and lincosamine resistance pheno-
types (11).
T-protein types were determined by slide
agglutination of trypsin-digested suspensions of
bacteria with rabbit type-specific antiserum
(SEVAC, Prague)(13).
The emm gene type of T-serotyped strains
was determined by polymerase chain reaction
(PCR)-enzyme-linked immunosorbent assay
(ELISA), as described by Saunders et al. (14).
Capture probes for the emm gene not described
by Saunders et al. were selected from the DNA
sequences encoding the N-terminal hypervariable
region of strains of types emm2, emm9, emm48,
and emm75 (GenBank accession nos. X56608,
U12002, U11961, and U11993).
PFGE was done (15) with the following
modifications. Cells were resuspended to an
optical density (OD)560nm = 1.0, and 4 ml of the
adjusted suspension was centrifuged. Pelleted
cells were resuspended in 200 µl of Pett IV buffer
(10 mM Tris, pH 7.2, 20 mM NaCl, 50 mM EDTA)
and mixed with 100  µl of 2% low-melting
agarose; incubation of plugs with lysozyme
solution (1 mg/ml) was reduced to 3 hours. Slices
of plugs were digested at 50ºC for 16 hours with
30 UI of the enzyme SfiI since it has proven
satisfactory in differentiating DNA fragments of
S. pyogenes (15,16). Digested inserts were
electrophoresed by using a CHEF-DR III
apparatus (BioRad), along with DNA size
standards (BioRad) under the following condi-
tions: 22 hours with an initial switch time of 20
seconds, rising on linear ramp  to 75 seconds at
6V/cm, with an included angle of 120ºC. Gels
were stained with ethidium bromide and
visualized under UV light with Imagestore 5000
ver.7.12 (Ultra-Violet Products Ltd, Cambridge,
England). Similarities among PFGE patterns
were established using the Dice coefficient and
Lane-Manager 2.1 (TDI, Madrid, Spain) com-
mercial computer software.
A clone was defined as a group of strains
expressing both the same characteristic
phenotype and genotype (PFGE pattern
similarity  ³ 90%).
Erythromycin Resistance
We studied 2,561 strains of S. pyogenes
isolated from 1988 to 1997 in Gipuzkoa; 309
(12.1%) were resistant to erythromycin. A report
of ErR in Gipuzkoa from 1984 to 1996 (11)
showed that until the end of 1990, erythromycin
resistance in S. pyogenes was low (1.2%, 13 of
1,060); after 1990, resistance increased, reaching
34.8% (87 of 250) of all S. pyogenes isolated in
1995. In 1997, resistance decreased to 13.7% (57
of 417). In Madrid and Vitoria, resistance to
erythromycin in 1996 was 22.4% (126 of 563) and
31.6% (43 of 136), respectively.
Among the ErR strains isolated in Gipuzkoa,
two phenotypes of resistance were found:
8 (2.6%) strains showed the classic MLSb
phenotype, while the other 301 (97.4%) strains
expressed the M phenotype, as shown by
susceptibility testing and confirmed by the
presence of the mefA gene (11). Of the 128 ErR
isolated in Madrid and Vitoria, 5 (3.9%) strains
(all from Madrid) displayed the MLSb phenotype,
while the remaining 123 (96.1%) showed the
M phenotype. The presence of the mefA gene was
searched for in 283 ErR with the M phenotype; it
was detected in all.
Biotyping, T Serotyping, emm Typing, and
PFGE of M-Phenotype ErR
Among the 424 ErR with the M phenotype,
only four biotypes (of 10 possible) were
identifiedbiotypes I, II, III, and V. In
Gipuzkoa, biotype III was the only biotype found
until 1990; between 1991 and 1997, biotypes I
and V comprised 275 (93.8%) of the 293 resistant
strains. Seven T-agglutination patterns were
found in Gipuzkoa, each one correlating with an
emm  type except for TB3264 (T1 emm1, T2
emm2, T4 emm4, T8.25 emm75, T12 emm12, and
T28 emm28). TB3264 biotype III was emm2, but
TB3264 biotype I was not typeable with any of
the 14 emm types assayed. Until 1990, type T12
emm12 was the only type found. Between 1991
and 1997, type T4 emm4 and T8.25 emm75
comprised 92.2% (270 of 293) of all isolates with237 Vol. 5, No. 2, AprilJune 1999 Emerging Infectious Diseases
Synopses
Table. Annual distribution of clones of M-phenotype erythromycin-resistant Streptococcus pyogenes
 Clonesa
Total M- E-O
Year phenotype A B C D (biotype/T type/emm type)
Gipuzkoa 1988-1990     8 7
Gipuzkoa 1991-1994   80   76   1 E (I/T1/emm1)
  1 F (I/T28/emm28)
Gipuzkoa 1995   83   31 18   29   1 G (I/TB3264/emm ntb)
  1 H (III/TB3264/emm2)
Gipuzkoa 1996   74   19 23   25   2 H
  1 E
  1 I (I/T4/emm4)
Gipuzkoa 1997   56 1     4   3   40   2 H
  2 J (V/T8,25/emm75)
  1 K (II/T2/emm2)
  1 L (III/Tnt/emm3)
Madrid 1996   90   12   2   68   6 M (III/T12/emm12)
  2 N (III/T12/emm12)
Vitoria 1996   33 1   30     1   1 O ((III/Tnt/emm3)
 Total 424c 9 172 46 163 23
aClone A: biotype III, type T12 emm12, pulsed-field gel electrophoresis (PFGE) pattern I; clone B: biotype I, type T4 emm4, PFGE
pattern II; clone C: biotype I, type T4 emm4, PFGE pattern III; clone D: biotype V, type T8.25 emm75, PFGE pattern IV.
bnt: nontypeable.
cEleven strains were not typed.
Figure 1. Pulsed-field gel electrophoresis of SfiI restriction
fragments of Streptococcus pyogenes DNAs of erythromycin-
resistant S. pyogenes.  Lanes 1-2, MLSb phenotype strains; lane 3,
clone F (biotype I, type T28, emm28); lanes 4-5, clone A (biotype III,
type T12, emm12); lanes 6-7, clone B (biotype I, type T4, emm4);
lanes 8-9, clone C (biotype I, type T4, emm4); lane 10, clone D
(biotype V, type T8.25, emm75); lanes 11-12, clone E (biotype I, type
T1, emm1); lane 13, DNA size standards (lambda ladder, 48.5 to
1,018 kb); lanes 14 and 16, clone H (biotype III, type TB3264, emm2);
and lane 15, clone G (biotype I, type TB3264 emm not typeable).
the M phenotype of resistance.
In Vitoria and Madrid, T4 emm4
and T8.25 emm75 types were
also the most frequently found.
Fifteen different PFGE pat-
terns were found among the 424
M phenotype ErR; 92% of these
strains belonged to four patterns
(clones A-D) (Table, Figure 1).
Among ErR with the MLSb
phenotype, eight PFGE patterns
were found. Each biotype/T-
serotype/emm-type combination
corresponded with one PFGE
pattern except on three occa-
sions. Three different PFGE
patterns that could be estab-
lished among ErR belonged to
biotype III/T12/emm12, two PFGE
patterns belonged to I/T4/emm4,
and another two patterns be-
longed to V/T8.25/emm75. The
types of other clones, their annual
distribution, and a dendrogram
showing their similarities are
given in the Table and Figure 2.238 Emerging Infectious Diseases Vol. 5, No. 2, AprilJune 1999
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Figure 2. A dendrogram showing the genetic
relationship of 15 clones of M-phenotype erythromycin-
resistant  Streptococcus pyogenes and two
erythromycin-sensitive strains (ErS) established
from pulsed-field gel electrophoresis patterns
obtained after SfiI digestion by using the Dice
coefficient and UPGMA and Lane Manager 2.1
software. Clone A (III/T12/emm12a); Clone B (I/T4/
emm4); Clone C (I/T4/emm4); Clone D (V/T8,25/
emm75); Clone E (I/T1/emm1); Clone F (I/T28/
emm28); Clone G (I/ TB3264/emm ntb); Clone H (III/
TB3264/emm2); Clone I (I/T4/emm4); Clone J (V/
T8,25/emm75); Clone K (II/T2/emm2); Clone L (III/T
nt/ emm nt); Clone M (III/T12/emm12); Clone N (III/
T12/emm12); Clone O (III/Tnt/emm nt); ErS T12 (III/
T12/emm12); ErS T4 (I/T4/emm4).
aBiotype/T-serotype/emm type.
bnt = nontypeable.
Genetic Relationship of ErR and
Erythromycin-Sensitive S. pyogenes
The genetic relationship of ErR and
erythromycin-sensitive  S. pyogenes with the
same biotype and T serotype was analyzed by
PFGE. In a sample of 360 erythromycin-
sensitive  S. pyogenes, biotypes I and III were the
most frequent (66.7%); T1 and T28 were the most
frequent T serotypes (30.6%). Only 8 (2.2%)
erythromycin-sensitive strains of biotype I,
serotype T4 were found. None of the 19 T8.25
erythromycin-sensitive strains found were
biotype V (18 biotype II, emm 75 and 1 biotype I,
emm nontypeable). Infrequent biotype and
T-serotype combinations among ErR, such as
I/T1 and I/T28, were frequently found among
erythromycin-sensitive strains. Similarities be-
tween PFGE patterns of most of the erythromy-
cin-sensitive and -resistant strains with the
same biotype and T-serotype combination was
less than 75%. Exceptions to this were several
III/T12, I/T1, and I/T28 erythromycin-sensitive
strains that had a close similarity (>90%) with
ErR of the same biotype and T-serotype
combination.
Four major clones of ErR were detected:
clone A (T12, emm12, biotype III, PFGE I), which
was present in Gipuzkoa until 1990; clone B (T4,
emm4, biotype I, PFGE II), which was introduced
in 1991; and clones C (T4, emm4, biotype I, PFGE
III) and D (T8,25, emm75, biotype V, PFGE IV),
which were introduced in 1995 and persisted
during 1996 and 1997. In Madrid and Vitoria,
89.4% (110) of the 123 M-phenotype strains
isolated in 1996 belonged to clones B and D.
Conclusions
In 1990, a new phenotype of erythromycin
resistance (first designated NR and later M) was
found in group A streptococci in Finland (7,17).
ErR with the M phenotype had a low level of
erythromycin resistance (8 mg/l to 16 mg/l) and
showed cross-resistance with the 14- and
15-membered macrolides; however, they showed
the same susceptibility to the 16-membered
macrolides and to clindamycin as the erythromy-
cin-susceptible strains (11). This M phenotype
was prevalent among S. pyogenes in Europe and
was the predominant phenotype of resistance
among ErR isolated in Finland (18,19), Sweden
(20), Austria (21), and Spain (9-11). In Italy, a
high prevalence of erythromycin-resistant
S. pyogenes was reported, but the prevalence of
the M-phenotype strains among ErR varied by
geographic area (22-24). Among the 437 ErR in
our study in Spain, 424 (97%) showed the
M phenotype; the mefA gene was detected and
studied in 283 of these strains.
The epidemiologic surveillance of S. pyogenes
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methods or both (as we did). Biotyping does not
need specialized personnel or equipment, and it
is useful, in combination with serotyping
methods, for a first approximation of the
epidemiologic characterization of S. pyogenes. In
this study, the most prevalent T serotypes
among ErR were infrequent among erythromy-
cin-sensitive strains and vice versa. M serotyping
is a classic typing method with at least 74 types
recognized, but because it is a very specialized
method and reagents are not available commer-
cially, it is restricted to a few reference centers. A
rapid PCR-ELISA to determine the emm gene
type was an accessible alternative to serology for
M-antigen typing.
Although the discriminatory power of
biotyping and serotyping is considered poor
because different genotypes may express the
same phenotypic characteristics (15,25,26),
these tests were of great value in our
epidemiologic surveillance. The biotype and
T-serotype combination was able to discriminate
between ErR and erythromycin-sensitive strains
and delimited most clones among ErR.
Genomic typing methods have rarely been
used in characterizing the epidemiology of
noninvasive  S.  pyogenes. Among these methods,
restriction endonuclease analysis of genomic
DNA (REA), random amplified polymorphic
DNA (RAPD), ribotyping, PFGE of chromosomal
DNA, and DNA sequence analysis have been
used with varying degrees of success (15,16,19,26-
28). PFGE patterns confirmed the results of
biotyping and serotyping and further distin-
guished among isolates within the same biotype
and T-serotype combination. However, PFGE is
a complex methodresults take at least 4 days to
obtainand expensive equipment and special-
ized personnel are needed.
Although the polyclonal nature of the ErR
strains was established in this study and
previously (18), most ErR belonged to only a few
clones. In Finland, 91% of the ErR isolated in
1994 were serotype T4 M4 and 88% constituted
one clone by RAPD and REA (19). In our study,
many clones were detected during the 10-year
period. Two of the four main clones comprised
78.8% of ErR. The clonal distribution of ErR in
Spain could be due to the introduction and
spread of ErR from other locations or to
mutations in S. pyogenes previously present in
our environment. ErR with the M phenotype
already existed in Gipuzkoa before 1990, and
serotype T12 was the only one found. From 1980
to 1988, serotype T12 was predominant among
ErR with the M phenotype in Sweden (20). In
Gipuzkoa, the first serotype T4 ErR strain was
isolated in 1991; until the end of 1994, 93.8% of
ErR isolated belonged to the same clone (clone B:
biotype I, type T4, emm4, PFGE II). Only three
biotype I serotype T4 erythromycin-sensitive
strains were detected before 1991. Clone B
probably did not emerge in Gipuzkoa from a
mutation of one of these uncommon sensitive
strains. Apart from the strains described in
Finland, Sweden, and Spain, strains with
M phenotype were isolated in Great Britain
before 1990 (4,29). Among these British and
Finnish strains, type T4 M4 was frequently
isolated (4,18,29). In a 1986 outbreak of 10
associated cases in Somerset, Great Britain,
isolates were group A, type M4 and resistant to
erythromycin (MIC 8 mg/l) but sensitive to
clindamycin (29). We do not know whether the
strains of clone B isolated in Spain are the same
as the ErR type T4 M4 found in Great Britain
and  Finland before 1991, but it is probable. In
Italy, serotypes T4 and T8.25 were found among
M-phenotype strains (22), which suggests that a
few clones have spread across Europe and caused
a regional epidemic. No erythromycin-sensitive
strains were detected in Gipuzkoa with the same
biotype/T-type/emm type combination as clone D.
We believe that clones B and D, the most
frequent among ErR in Spain, were of epidemic
origin and that clone B probably came from
northern or western Europe.
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